Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Mouse (Murine) Kallikrein 7 Antikörper:
anti-Rat (Rattus) Kallikrein 7 Antikörper:
anti-Human Kallikrein 7 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Polyclonal Kallikrein 7 Primary Antibody für IHC (p), WB - ABIN652197
Planque, de Monte, Guyetant, Rollin, Desmazes, Panel, Lemarié, Courty: KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer. in Biochemical and biophysical research communications 2005
Human Polyclonal Kallikrein 7 Primary Antibody für IF (p), IHC (p) - ABIN676028
Yamamoto, Yamamoto, Yamada, Hasegawa, Hongo, Oda, Amizuka: Hertwig's epithelial root sheath cell behavior during initial acellular cementogenesis in rat molars. in Histochemistry and cell biology 2014
Higher hK7 expression is associated with cervical adenocarcinomas
Prolonged Klk7 neutralization provokes profound abnormalities in Klk7 function, due to pH-induced high serine protease (zeige F2 Antikörper) activity that degrades lipid processing enzymes and corneodesmosomes proteins.
This report demonstrates that concurrent loss of KLK5 (zeige KLK5 Antikörper) and KLK7 associates with a poor clinical outcome in Squamous-Cell Carcinoma and could therefore serve as prognostic marker in this disease.
Data demonstrate that elevated levels of KLK6, KLK7 and KLK9 proteins are associated with poor glioblastoma patients survival.
Our findings suggest that serum KLK7 may be a valuable diagnostic biomarker for cervical cancer, and may help to determine the individual prognosis of these patients.
KLK6 (zeige KLK1 Antikörper) and KLK7 mRNA and protein overexpression is directly associated with early-stage ovarian tumors.
Proteolytic cleavage of midkine (zeige MDK Antikörper), CYR61 (zeige CYR61 Antikörper), and tenascin-C (zeige TNC Antikörper) govern the pathophysiological roles of KLK7.
Early-stage oral squamous cell carcinoma and high KLK7 mRNA levels were correlated with the rs10581213(wt/ins + ins/ins (zeige INS Antikörper)) genotypes
These results demonstrate the aberrant expression of KLK7 in colon cancer cells and tissues and its involvement in cell proliferation in vitro and in vivo.
Daata indicate that the peptide Abz-NLY( downward arrow)RVE-Q-EDDnp is the best synthetic substrate for Kallikrein-related peptidase 7 (KLK7) [kcat/Km=455 (mMs)(-1)].
KLK7 and KLK14 (zeige KLK14 Antikörper) gene expression can be regarded as markers of poor prognosis for colorectal cancer patients with discriminating power between CC and adenoma patients.
Prochemerin processing protease converts prochemerin into active chemerinF; the activating truncation by the protease may trigger a structural C-terminal rearrangement leading to increased affinity of chemerin (zeige RARRES2 Antikörper) to chemokine (zeige CCL1 Antikörper)-like receptor (CMKLR)1 (zeige CMKLR1 Antikörper).
This gene encodes a member of the kallikrein subfamily of serine proteases. These enzymes have diverse physiological functions and many kallikrein genes are biomarkers for cancer. The encoded protein has chymotrypsin-like activity and plays a role in the proteolysis of intercellular cohesive structures that precedes desquamation, the shedding of the outermost layer of the epidermis. The encoded protein may play a role in cancer invasion and metastasis, and increased expression of this gene is associated with unfavorable prognosis and progression of several types of cancer. Polymorphisms in this gene may play a role in the development of atopic dermatitis. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, which is one of fifteen kallikrein subfamily members located in a gene cluster on chromosome 19.
kallikrein 7 (chymotryptic, stratum corneum)
, protease, serine, 6
, serine protease 6
, stratum corneum chymotryptic enzyme
, kallikrein related-peptidase 7 (chymotryptic, stratum corneum)
, signal protein